XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Comprehensive Income - EUR (€)
€ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Statement of comprehensive income [abstract]      
Net income € 2,263 € 3,456 € 5,436
Attributable to equity holders of Sanofi 2,246 3,430 5,400
Attributable to non-controlling interests 17 26 36
Other comprehensive income:      
Actuarial gains/(losses) 235 141 (171)
Change in fair value of equity instruments included in financial assets and financial liabilities (10) 3 97
Tax effects (59) (59) (3)
Items not subsequently reclassifiable to profit or loss 166 85 (77)
Change in fair value of debt instruments included in financial assets (5) 6 21
Change in fair value of cash flow hedges (3) 1 (1)
Change in currency translation differences 1,040 (1,057) (1,540)
Tax effects 35 (8) (6)
Items subsequently reclassifiable to profit or loss 1,067 (1,058) (1,526)
Other comprehensive income for the period, net of taxes 1,233 (973) (1,603)
Comprehensive income 3,496 2,483 3,833
Attributable to equity holders of Sanofi 3,471 2,465 3,810
Attributable to non-controlling interests € 25 € 18 € 23